Evidence map›Paper›PMID 36606487›Full record

ArticleJournal of cell science2023

Incorporation of 53BP1 into phase-separated bodies in cancer cells during aberrant mitosis.

Marina Bleiler, Aiyana Cyr, Dennis L Wright, Charles Giardina

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cell science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Marina BleilerDepartment of Molecular and Cell Biology, University of Connecticut, Storrs, CT 06269, USA.ORCID 0000-0003-2256-589X
Aiyana CyrDepartment of Molecular and Cell Biology, University of Connecticut, Storrs, CT 06269, USA.
Dennis L WrightDepartment of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USA.
Charles GiardinaDepartment of Molecular and Cell Biology, University of Connecticut, Storrs, CT 06269, USA.
University of Connecticut · US

Funding

STED Super Resolution Microscope for a Core FacilityS10OD023618 · OD · UNIVERSITY OF CONNECTICUT STORRS · PI O'CONNELL, CHRISTOPHER B · 2018 to 2018
$1000k
(1) Intestinal Organoid Models for APC LOHR21CA208638 · NCI · UNIVERSITY OF CONNECTICUT STORRS · PI GIARDINA, CHARLES A. · 2016 to 2017
$425k
NCI NIH HHS R21 CA208638NIH HHS R21CA208638NIH HHS S10 OD023618
6 · The paper itself

Abstract

53BP1 (also known as TP53BP1) is a key mediator of the non-homologous end joining (NHEJ) DNA repair pathway, which is the primary repair pathway in interphase cells. However, the mitotic functions of 53BP1 are less well understood. Here, we describe 53BP1 mitotic stress bodies (MSBs) formed in cancer cell lines in response to delayed mitosis. These bodies displayed liquid-liquid phase separation characteristics, were close to centromeres, and included lamin A/C and the DNA repair protein RIF1. After release from mitotic arrest, 53BP1 MSBs decreased in number and moved away from the chromatin. Using GFP fusion constructs, we found that the 53BP1 oligomerization domain region was required for MSB formation, and that inclusion of the 53BP1 N terminus increased MSB size. Exogenous expression of 53BP1 did not increase MSB size or number but did increase levels of MSB-free 53BP1. This was associated with slower mitotic progression, elevated levels of DNA damage and increased apoptosis, which is consistent with MSBs suppressing a mitotic surveillance by 53BP1 through sequestration. The 53BP1 MSBs, which were also found spontaneously in a subset of normally dividing cancer cells but not in non-transformed cells (ARPE-19), might facilitate the survival of cancer cells following aberrant mitoses. This article has an associated First Person interview with the first author of the paper.

Indexed as

DNA RepairNeoplasmsTumor Suppressor p53-Binding Protein 1Cell Line, TumorChromatinDNA DamageDNA End-Joining RepairHumansMitosisChromatinTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 153BP1ARPE-19Colon cancer cell linesLamin A/CMitotic arrestMitotic stressRIF1

Identifiers

PMID36606487
PMCPMC10112977
OpenAlexW4313648774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.